| Helton Hearing Care | |
|
1008 N. 7th Ave., Suite H, Bozeman, MT 59715-2567 | |
| (406) 586-0914 | |
| (406) 586-6667 |
| Full Name | Helton Hearing Care |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 1008 N. 7th Ave., Bozeman, Montana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558684464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1245 (Montana) | Primary |
| 332S00000X | Hearing Aid Equipment | 400 (Montana) | Secondary |
| Provider Name | William M Helton |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1639307697 PECOS PAC ID: 2163559287 Enrollment ID: I20100422000114 |
News Archive
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced the first patient has been dosed in its Halo-301 | Pancreatic study, a Phase 3 clinical trial in previously untreated metastatic pancreatic cancer patients.
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences.
IBM today announced that the University at Buffalo (UB) Center of Excellence in Bioinformatics, The State University of New York, will use IBM technologies and research expertise to study the structure and behavior of human proteins. The outcome of this research could lead to more targeted drugs to treat diseases such as cancer, Alzheimer's, AIDS and multiple sclerosis.
According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.
› Verified 6 days ago
| Provider Name | Alyson R Holmes |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1588015275 PECOS PAC ID: 7719270305 Enrollment ID: I20160719002253 |
News Archive
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced the first patient has been dosed in its Halo-301 | Pancreatic study, a Phase 3 clinical trial in previously untreated metastatic pancreatic cancer patients.
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences.
IBM today announced that the University at Buffalo (UB) Center of Excellence in Bioinformatics, The State University of New York, will use IBM technologies and research expertise to study the structure and behavior of human proteins. The outcome of this research could lead to more targeted drugs to treat diseases such as cancer, Alzheimer's, AIDS and multiple sclerosis.
According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.
› Verified 6 days ago
| Provider Name | Kendra E Fajardo |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1649919721 PECOS PAC ID: 5991170094 Enrollment ID: I20230403001234 |
News Archive
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced the first patient has been dosed in its Halo-301 | Pancreatic study, a Phase 3 clinical trial in previously untreated metastatic pancreatic cancer patients.
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences.
IBM today announced that the University at Buffalo (UB) Center of Excellence in Bioinformatics, The State University of New York, will use IBM technologies and research expertise to study the structure and behavior of human proteins. The outcome of this research could lead to more targeted drugs to treat diseases such as cancer, Alzheimer's, AIDS and multiple sclerosis.
According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Helton Hearing Care 1008 N. 7th Ave., Suite H, Bozeman, MT 59715-2567 Ph: (406) 586-0914 | Helton Hearing Care 1008 N. 7th Ave., Suite H, Bozeman, MT 59715-2567 Ph: (406) 586-0914 |
News Archive
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced the first patient has been dosed in its Halo-301 | Pancreatic study, a Phase 3 clinical trial in previously untreated metastatic pancreatic cancer patients.
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences.
IBM today announced that the University at Buffalo (UB) Center of Excellence in Bioinformatics, The State University of New York, will use IBM technologies and research expertise to study the structure and behavior of human proteins. The outcome of this research could lead to more targeted drugs to treat diseases such as cancer, Alzheimer's, AIDS and multiple sclerosis.
According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.
› Verified 6 days ago
Marci Kim Lund, AU.D., F-AAA, CCC- Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1008 N 7th Ave Ste H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 | |
Ryanne Tindell, AU.D. Audiologist Medicare: May Accept Medicare Assignments Practice Location: 1008 N 7th Ave Ste H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 | |
Katelyn Ellen Thompson, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1008 N 7th Ave Ste H, Bozeman, MT 59715 Phone: 406-586-0914 | |
Jennifer D Sabers, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 925 Highland Blvd, Suite 1160, Bozeman, MT 59715 Phone: 406-587-5000 Fax: 406-585-5068 | |
Alyson Renee Holmes, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1008 N 7th Ave, Suite H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 | |
Dr. William M Helton Iii, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1008 N 7th Ave, Suite H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 |